We are live on ! Find out more
CCXI

ChemoCentryx, Inc.

Delisted

CCXI was delisted on the 19th of October, 2022.

65 hedge funds and large institutions have $176M invested in ChemoCentryx, Inc. in 2014 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 5

29% more capital invested

Capital invested by funds: $136M → $176M (+$39.9M)

14% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 21

8% more funds holding

Funds holding: 6065 (+5)

8% more call options, than puts

Call options by funds: $185K | Put options by funds: $172K

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
65
Holders Change
+5
Holders Change %
+8.33%
% of All Funds
1.88%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
10
Increased
24
Reduced
21
Closed
5
Calls
$185K
Puts
$172K
Net Calls
+$13K
Net Calls Change
+$191K
Name Holding Trade Value Shares
Change
Change in
Stake
Ohio Public Employees Retirement System (OPERS)
26
Ohio Public Employees Retirement System (OPERS)
Ohio
$496K -$65K -9,348 -11%
BPC
27
Banque Pictet & Cie
Switzerland
$477K +$146K +21,028 +41%
RA
28
Royce & Associates
New York
$464K -$1.47M -212,000 -75%
BIM
29
BlackRock Investment Management
Delaware
$457K +$5.73K +824 +1%
Millennium Management
30
Millennium Management
New York
$405K +$313K +45,011 +280%
ProShare Advisors
31
ProShare Advisors
Maryland
$383K +$258K +37,080 +180%
KeyBank National Association
32
KeyBank National Association
Ohio
$375K
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$371K +$410K +59,000 New
Jane Street
34
Jane Street
New York
$358K -$238K -34,190 -39%
Charles Schwab
35
Charles Schwab
California
$343K +$8.76K +1,260 +2%
BBA
36
Baker Bros. Advisors
New York
$332K
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$293K
CS
38
Credit Suisse
Switzerland
$289K -$270K -38,901 -47%
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
$278K -$885K -127,436 -75%
Bank of America
40
Bank of America
North Carolina
$257K -$69.4K -9,987 -20%
AG
41
Aperio Group
California
$236K +$247K +35,619 New
TA
42
Teachers Advisors
New York
$225K
DekaBank Deutsche Girozentrale
43
DekaBank Deutsche Girozentrale
Germany
$176K +$184K +26,500 New
Barclays
44
Barclays
United Kingdom
$168K +$82.3K +11,839 +74%
PPA
45
Parametric Portfolio Associates
Washington
$144K +$32.2K +4,634 +27%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$137K -$8.34K -1,200 -5%
Morgan Stanley
47
Morgan Stanley
New York
$128K -$321K -46,157 -70%
NFA
48
Nationwide Fund Advisors
Ohio
$125K
Swiss National Bank
49
Swiss National Bank
Switzerland
$125K
VKH
50
Virtu KCG Holdings
New York
$115K +$33.5K +4,817 +38%

CCXI Hedge Fund Activity: Q1 2014 in Review

65 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q1 2014, worth a combined $176M — up 29% from $136M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new CCXI positions and 5 closed out — a net gain of 5 holders — while 24 added to existing stakes and 21 trimmed.

The largest buyer was Westfield Capital Management, opening a new position worth an estimated $9.74M. The largest seller was Great Point Partners, cutting an estimated $5.21M.

  • 65 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q1 2014, up from 60 in Q4 2013.
  • Funds reported $176M of ChemoCentryx, Inc. stock for Q1 2014, up 29% quarter-over-quarter.
  • 10 funds opened new ChemoCentryx, Inc. positions in Q1 2014 and 5 closed out, a net change of +5 holders.
  • The largest ChemoCentryx, Inc. buyer in Q1 2014 was Westfield Capital Management, an estimated $9.74M added.
  • The largest ChemoCentryx, Inc. seller in Q1 2014 was Great Point Partners, an estimated $5.21M sold.

Based on aggregated 13F filings for Q1 2014.